For context, bariatric surgery typically results in 2530% weight loss, making retatrutide potentially competitive with surgical outcomesbut without the scalpel
Key takeaways: across all five SURMOUNT trials, Zepbound consistently produced 14% to 22.5% average weight loss, with the head-to-head data confirming superior efficacy compared to the leading semaglutide-based alternative
We also maintain reliable customer service to ensure a smooth experience, from pre-sale inquiries to after-sales support
I started the process 90 days ago and have already lost 30 pounds
This is the core of the individualized dosing model
Las proyecciones indican que, de mantenerse la tendencia, el porcentaje podra alcanzar el 73,2% en 2030